Should Drug Manufacturers - Specialty & Generic Stock C21 Investments Inc (CXXIF) Be in Your Portfolio Wednesday?
Wednesday, March 01, 2023 04:02 PM | InvestorsObserver Analysts
Mentioned in this article
C21 Investments Inc (CXXIF) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CXXIF received an overall rating of 44, which means that it scores higher than 44 percent of all stocks. C21 Investments Inc also achieved a score of 74 in the Drug Manufacturers - Specialty & Generic industry, putting it above 74 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.
CXXIF has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on CXXIF!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With C21 Investments Inc Stock Today?
C21 Investments Inc (CXXIF) stock is trading at $0.26 as of 1:41 PM on Wednesday, Mar 1, a drop of -$0.04, or -11.98% from the previous closing price of $0.30. The stock has traded between $0.26 and $0.30 so far today. Volume today is high. So far 23,458 shares have traded compared to average volume of 16,909 shares.
Click Here to get the full Stock Report for C21 Investments Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter